Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficiency - Summary of Warrants Activity (Details)

v3.5.0.2
Stockholders' Deficiency - Summary of Warrants Activity (Details) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Equity [Abstract]    
Number of Shares Warrants outstanding 54,088,323 37,895,137
Number of Shares Warrants granted 8,330,014 18,825,355
Number of Shares Warrants exercised (959,000)
Number of Shares Warrants canceled/forfeited/expired (1,374,746) (1,673,169)
Number of Shares Warrants outstanding 61,043,591 54,088,323
Number of Shares Warrants exercisable 61,043,591  
Weighted Average Exercise Price Warrants outstanding at Beginning Balance $ 1.28 $ 1.42
Weighted Average Exercise Price Warrants granted .87 1.00
Weighted Average Exercise Price Warrants exercised 0.69
Weighted Average Exercise Price Warrants canceled/forfeited/expired 1.55 1.58
Weighted Average Exercise Price Warrants outstanding at Ending Balance 1.08 [1] $ 1.28
Weighted Average Exercise Price Warrants exercisable [1] $ 1.08  
Weighted Average Remaining Life In Years Outstanding 2 years 8 months 12 days  
Weighted Average Remaining Life In Years Exercisable 2 years 8 months 12 days  
Aggregate Intrinsic Value Outstanding  
Aggregate Intrinsic Value Exercisable  
[1] During 2015, the exercise price of warrants to purchase an aggregate of 19,599,999 shares of common stock was reduced to $0.70 per share from exercise prices ranging from $1.05 to $1.00 per share.